These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 29870497)

  • 1. Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions.
    Ugarte A; Danza A; Ruiz-Irastorza G
    Curr Opin Rheumatol; 2018 Sep; 30(5):482-489. PubMed ID: 29870497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
    Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
    Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus.
    Paredes-Ruiz D; Martin-Iglesias D; Ruiz-Irastorza G
    Expert Rev Clin Immunol; 2024 Apr; 20(4):359-373. PubMed ID: 38112074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.
    Ruiz-Irastorza G; Ugarte A; Saint-Pastou Terrier C; Lazaro E; Iza A; Couzi L; Saenz R; Richez C; Porta S; Blanco P
    Autoimmun Rev; 2017 Aug; 16(8):826-832. PubMed ID: 28564619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.
    González-Echavarri C; Capdevila O; Espinosa G; Suárez S; Marín-Ballvé A; González-León R; Rodríguez-Carballeira M; Fonseca-Aizpuru E; Pinilla B; Pallarés L; Ruiz-Irastorza G;
    Lupus; 2018 Dec; 27(14):2253-2261. PubMed ID: 30451641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of high versus low-medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis.
    Ruiz-Arruza I; Barbosa C; Ugarte A; Ruiz-Irastorza G
    Autoimmun Rev; 2015 Oct; 14(10):875-9. PubMed ID: 26044819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs.
    Ruiz-Irastorza G; Bertsias G
    Rheumatology (Oxford); 2020 Dec; 59(Suppl5):v69-v81. PubMed ID: 33280011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seventy years after Hench's Nobel prize: revisiting the use of glucocorticoids in systemic lupus erythematosus.
    Ruiz-Irastorza G; Ugarte A; Ruiz-Arruza I; Khamashta M
    Lupus; 2020 Sep; 29(10):1155-1167. PubMed ID: 32539657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent findings about antimalarials in cutaneous lupus erythematosus: What dermatologists should know.
    Teboul A; Arnaud L; Chasset F
    J Dermatol; 2024 Jul; 51(7):895-903. PubMed ID: 38482997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group.
    Tsakonas E; Joseph L; Esdaile JM; Choquette D; Senécal JL; Cividino A; Danoff D; Osterland CK; Yeadon C; Smith CD
    Lupus; 1998; 7(2):80-5. PubMed ID: 9541091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednisone in lupus nephritis: how much is enough?
    Ruiz-Irastorza G; Danza A; Perales I; Villar I; Garcia M; Delgado S; Khamashta M
    Autoimmun Rev; 2014 Feb; 13(2):206-14. PubMed ID: 24189280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus: review of synthetic drugs.
    Tsang-A-Sjoe MW; Bultink IE
    Expert Opin Pharmacother; 2015; 16(18):2793-806. PubMed ID: 26479437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus.
    Ruiz-Arruza I; Ugarte A; Cabezas-Rodriguez I; Medina JA; Moran MA; Ruiz-Irastorza G
    Rheumatology (Oxford); 2014 Aug; 53(8):1470-6. PubMed ID: 24681836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on antimalarials and systemic lupus erythematosus.
    Ruiz-Irastorza G; Martín-Iglesias D; Soto-Peleteiro A
    Curr Opin Rheumatol; 2020 Nov; 32(6):572-582. PubMed ID: 32890029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study.
    de Luca Montes RA; Huq M; Godfrey T; Oon S; Calderone A; Kandane-Rathnayake R; Louthrenoo W; Luo SF; Jan Wu YJ; Golder V; Lateef A; Navarra SV; Zamora L; Hamijoyo L; Sockalingam S; An Y; Li Z; Katsumata Y; Harigai M; Chan M; Goldblatt F; O'Neill S; Lau CS; Cho J; Hoi A; Karyekar CS; Morand EF; Nikpour M
    Adv Rheumatol; 2024 May; 64(1):38. PubMed ID: 38720354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
    Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
    Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long-Term Disease Control: An Observational Study.
    Ruiz-Arruza I; Lozano J; Cabezas-Rodriguez I; Medina JA; Ugarte A; Erdozain JG; Ruiz-Irastorza G
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):582-591. PubMed ID: 28704598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.
    Ugarte-Gil MF; Wojdyla D; Pastor-Asurza CA; Gamboa-Cárdenas RV; Acevedo-Vásquez EM; Catoggio LJ; García MA; Bonfá E; Sato EI; Massardo L; Pascual-Ramos V; Barile LA; Reyes-Llerena G; Iglesias-Gamarra A; Molina-Restrepo JF; Chacón-Díaz R; Alarcón GS; Pons-Estel BA
    Lupus; 2018 Apr; 27(4):536-544. PubMed ID: 28857715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus: An approach to pharmacologic interventions.
    El Hussein MT; Wong C
    Nurse Pract; 2023 Jul; 48(7):37-46. PubMed ID: 37368557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.